Wednesday May 22, 2019 Change 0.68% Price $19.20
Chart period: 2019-02-25 - 2019-05-22
VOLUME
Buy
TREND
Sell
MV LONG
Buy

MV SHORT
Buy

PIVOT
Buy

MACD
Sell

Will AXDX stock price go up or down on Thu, 23 May 2019?

Predict

Accelerate Diagnostics Forecast and Stock Analysis

Technical AXDX stock analysis for Wednesday May 22, 2019.

Hold candidate since 2019-05-22
Shorts n/a
Insider % n/a
Institutional % 59.20%
Beta 1.29
ROA -46.32%
Price to book USD 24.09
P/E Ratio -11.66
Next Earnings Date 2019-08-05


Accelerate Diagnostics gained 0.68% in the last trading day ( Wednesday, 22nd May 2019 ), rising from $19.07 to $19.20 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During day the stock fluctuated 3.72% from a day low at $18.84 to a day high of $19.54. The price has been going up and down for this period, and there has been a -4% loss for the last 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 38 686 more shares were traded than the day before. In total, 182 814 shares bought and sold for approximately $3.51 million.

Quick summary:

  • 30 day high of the AXDX stock price was $20.97 and low was $17.75.
  • 90 day high was $22.42 and low was $17.65.
  • 52 week high for the Accelerate Diagnostics - $24.75 and low - $10.23.

Trend

Accelerate Diagnostics lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -9.18% during the next 3 months and, with 90% probability hold a price between $15.24 and $18.49 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

Accelerate Diagnostics holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $19.17 and $19.10. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday May 20, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 44 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Accelerate Diagnostics finds support from accumulated volume at $19.00.

Support: $19.00 Price: $19.20 Resistance: $19.82

Risk

This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $0.70 (3.72%) between high and low. For the last week, the stock has had a daily average volatility of 4.37%.

Our recommended stoploss: $18.03 (-6.09%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 2 days ago.)

4.37 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Evaluation:

Accelerate Diagnostics holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Hold/Accumulate.

Hold/Accumulate Upgraded
Previous Hold Today AXDX ranks #1531 as HOLD CANDIDATE #1531 Next Hold
AXDX $19.20 ($0.13 0.68%)
AXDX is up $0.13 today, but where's it headed in 2019?
Zacks Investment Research is releasing its prediction for AXDX based on the 1-3 month system that more than doubles the S&P 500.

This report is free today for StockInvest.us readers.

Click here – the AXDX analysis is free »

Will AXDX stock price go up or down
on Thu, 23 May 2019?

Predict

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank